Decorin attenuates gliotic scar formation in the rat cerebral hemisphere

Experimental Neurology

Volumn 159, Issue 2, 1999, Pages 504-510

  Logan, Ann ^a   Baird, Andrew ^b   Berry, Martin ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Selective Genetics   (United States)

^c AGKI ^*  (United Kingdom)

Author keywords

Central nervous system; Cytokines; Decorin; Fibrosis; Gliosis; Injury; Scar inhibition; Scarring; Transforming growth factor

Indexed keywords

DECORIN; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ANIMAL CELL; ARTICLE; ASTROCYTOSIS; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROGENESIS; FIBROSIS; HEMISPHERE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION;

EID: 0032848943     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7180     Document Type: Article

References (29)

1. Baghdassarian-Chalaye D., Toru-Delbauffe D., Gaveret J. M., Pierre M. Effects of transforming growth factor β1 on the extracellular matrix and cytoskeleton of cultured astrocytes. Glia. 7:1993;193-202.
2. Border W. A., Noble N. A. Natural inhibitor of transforming growth factor β protects against scarring in experimental kidney disease. Nature. 360:1994;361-364.
3. Cui W., Ackhurst R. J. Transforming growth factor βs: Biochemistry and biological activities in vivo and in vitro. LeRoith D., Bondy C. Growth Factors in Health and Disease. 1996;319-356 JAI Press, Greenwich.
4. Flanders K., Ludecke G., Renzing J., Hamm C., Cissel D., Unsicker K. Effects of TGFβ's and bFGF on astroglial cell growth and gene expression in vitro. Mol. Cell. Neurosci. 4:1993;406-417.
5. Gagelin C., Pierre M., Gaveret J-M., Toru-Delbauffe D. Rapid TGFβ1 effects on actin cytoskeleton of astrocytes: Comparison with other factors and implications for cell motility. Glia. 13:1995;283-293.
6. Giri S. N., Hyde D. M., Braun R. K., Gaarde W., Harper J. R., Pierschbacher M. D. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem. Pharmacol. 54:1997;1205-1216.
7. Heino J., Massague J. Transforming growth factor β switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J. Biol. Chem. 36:1989;21806-21811.
8. Hurwitz A., Lyman W., Berman J. Tumour necrosis factor alpha and transforming growth factor β upregulate astrocyte expression of monocyte chemoattractant protein-1. J. Neuroimmunol. 57:1995;193-198.
9. Ignotz R. A., Massague J. Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:1989;4337-4345.
10. Ignotz R. A., Heino J., Massague J. Regulation of cell adhesion receptors by transforming growth factor β: Regulation of vitronectin receptor and LFA-1. J. Biol. Chem. 264:1989;389-392.
11. Isaka Y., Brees D. K., Ikegaya K., Kaneda Y., Imai E., Noble N. A., Border W. A. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med. 2:1996;418-423.
12. Kerr L. D., Miller D. B., Matrisian L. M. TGFβ1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell. 61:1990;267-278.
13. Kitazawa K., Tada T. Elevation of transforming growth factor-β in cerebrospinal fluid of patients with communicating hydrocephalus after sub-arachnoid haemorrhage. Stroke. 25:1994;1400-1404.
14. Krupinski J., Kumar P., Kumar S., Kaluza J. Increased expression of TGF-β in brain tissue after ischemic stroke in humans. Stroke. 27:1996;852-857.
15. Labourdette G., Thiery J., Laeng P., Perraud F., Lawrence D., Pettman B. Transforming growth factor β1 modulates the effects of basic fibroblast growth factor on growth and phenotypic expression of rat astroblasts in vitro. J. Cell Biol. 144:1990;473-484.
16. Laiho M., Saksela O., Andreasen P. A., Keski-Oja J. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor β J. Cell Biol. 103:1986;2403-2410.
17. Logan A., Berry M. Cellular response of central nervous system tissue to invasive therapeutic measures. Methods Neurosci. 21:1994;3-19.
18. Logan A., Berry M., Gonzalez A. M., Frautschy S. A., Sporn M. B., Baird A. Effects of transforming growth factor β1 on scar production in the injured central nervous system. Eur. J. Neurosci. 6:1994;355-363.
19. Logan A., Frautschy S. A., Gonzalez A. M., Sporn M. B., Baird A. Enhanced expression of transforming growth factor β1 in the rat brain after a localised cerebral injury. Brain Res. 587:1992;216-225.
20. Logan A., Green J., Hunter A., Jackson R., Berry M. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-β2. Eur. J. Neurosci. 11:1999;2367-2374.
21. Lund L. R., Riccio A., Andreasen P. A., Nielsen L. S., Kristensen P., Laiho M., Saksela O., Blasi F., Dano K. Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator-inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J. 6:1987;1281-1286.
22. Prat B. M., McPherson J. M. TGF-β in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev. 8:1997;267-292.
23. Stichel C. C., Kappler J., Junghans U., Koops A., Kresse H., Muller H. W. Differential expression of the small chondroitin/dermatan sulfate proteoglycans decorin and biglycan after injury of the adult rat brain. Brain Res. 704:1995;263-274.
24. Toru-Delbauffe D., Baghdassarian-Chalaye D., Gaveret J. M., Courtin F., Pomerance M., Pierre M. Effects of transforming growth factor β1 on astroglial cells in culture. J. Neurochem. 54:1990;1056-1061.
25. Varga J., Rosenbloom J., Jimenez S. A. Transforming growth factor beta causes a persistant increase in steady-state amounts for type I and type III collagen and fibronectin mRNAs in normal dermal human fibroblasts. Biochem. J. 297:1987;597-604.
26. Wahl S. M., Hunt D. A., Wakefield L. M., McCartney-Francis N., Wahl L. M., Roberts A. B., Sporn M. B. Transforming growth factor β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA. 84:1987;5788-5792.
27. Wrana J. L., Sodek J., Ber R. L., Bellows C. G. The effects of platelet-derived transforming growth factor-β on normal diploid gingival fibroblasts. Eur. J. Biochem. 159:1986;69-76.
28. Wyss-Coray T., Masliah E., Mallory M., McConlogue L., Johnson-Wood K., Lin C., Mucke L. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature. 389:1997;603-606.
29. Yamaguchi Y., Mann D. M., Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature. 346:1990;281-284.